30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Cidara Therapeutics Inc (CDTX)

Track

Stock chart
Ticker: CDTX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Ward Shane
COO & CLO
1 sale — total 2,191,747 USD
Planned sale 10 Dec 2025
Value US$4,412,843.26 | Price 387.76 | Shares 20,524
Planned sale 11 Sep 2025
Value US$3,577,065.75 | Price 380.26 | Shares 12,876
Buy 26 Jun 2025
Value US$99,999,988.00 | Price 44.00 | Shares 2,272,727
Buy 3 Jun 2025
Value US$24,614.10 | Price 23.44 | Shares 1,050
Buy 2 Jun 2025
Value US$49,281.47 | Price 21.71 | Shares 2,270
Planned sale 11 Mar 2025
Value US$38,939.69 | Price 21.96 | Shares 1,773
Planned sale 11 Mar 2025
Value US$36,542.11 | Price 21.96 | Shares 1,664
Planned sale 11 Sep 2024
Value US$10,752.31 | Price 11.64 | Shares 924
Planned sale 11 Sep 2024
Value US$10,580.12 | Price 11.64 | Shares 909
Buy 7 Jun 2024
Value US$105,680.00 | Price 13.21 | Shares 8,000
Planned sale 11 Mar 2024
Value US$14,085.22 | Price 0.67 | Shares 21,029
Planned sale 11 Mar 2024
Value US$12,679.98 | Price 0.67 | Shares 18,931
Planned sale 11 Mar 2024
Value US$13,712.82 | Price 0.67 | Shares 20,473
Planned sale 11 Mar 2024
Value US$13,839.41 | Price 0.67 | Shares 20,662
Planned sale 11 Sep 2023
Value US$17,810.13 | Price 0.95 | Shares 18,793
Sale 11 Sep 2023
Value US$17,508.61 | Price 0.95 | Shares 18,469
Planned buy 14 Aug 2023
Value US$9,700.00 | Price 0.97 | Shares 10,000
Buy 8 Aug 2023
Value US$47,885.00 | Price 0.96 | Shares 50,000
Buy 27 Mar 2023
Value US$51,855.00 | Price 1.04 | Shares 50,000
Planned sale 13 Mar 2023
Value US$11,020.59 | Price 1.53 | Shares 7,203
Planned sale 13 Mar 2023
Value US$6,623.37 | Price 1.53 | Shares 4,329
Sale 13 Mar 2023
Value US$11,569.86 | Price 1.53 | Shares 7,562
Planned sale 13 Mar 2023
Value US$10,171.44 | Price 1.53 | Shares 6,648
Sale 12 Jan 2023
Value US$14,176.80 | Price 1.20 | Shares 11,814
Sale 19 Sep 2022
Value US$12,034.95 | Price 0.77 | Shares 15,642
Sale 12 Sep 2022
Value US$11,094.70 | Price 0.68 | Shares 16,199
Planned sale 12 Sep 2022
Value US$12,655.58 | Price 0.68 | Shares 18,478
Planned sale 12 Sep 2022
Value US$12,437.10 | Price 0.68 | Shares 18,159
Sale 21 Mar 2022
Value US$529.74 | Price 0.81 | Shares 654
Sale 11 Mar 2022
Value US$670.95 | Price 0.71 | Shares 945
Sale 5 Jan 2022
Value US$1,565.00 | Price 1.25 | Shares 1,252
Sale 5 Jan 2022
Value US$6,416.25 | Price 1.25 | Shares 5,133
Sale 5 Jan 2022
Value US$520.00 | Price 1.25 | Shares 416
Buy 12 Nov 2021
Value US$79,530.00 | Price 1.59 | Shares 50,000
Buy 12 Nov 2021
Value US$30,800.00 | Price 1.54 | Shares 20,000
Buy 13 Sep 2021
Value US$14,822.50 | Price 2.12 | Shares 7,000
Sale 1 Apr 2021
Value US$3,130.82 | Price 2.66 | Shares 1,177
Sale 1 Apr 2021
Value US$1,577.38 | Price 2.66 | Shares 593
Sale 1 Apr 2021
Value US$3,907.54 | Price 2.66 | Shares 1,469
Sale 5 Jan 2021
Value US$1,697.44 | Price 2.06 | Shares 824
Sale 5 Jan 2021
Value US$5,908.08 | Price 2.06 | Shares 2,868
Sale 5 Jan 2021
Value US$5,908.08 | Price 2.06 | Shares 2,868
Buy 10 Nov 2020
Value US$100,015.00 | Price 40.01 | Shares 2,500
Planned buy 10 Nov 2020
Value US$100,015.00 | Price 2.00 | Shares 50,000
Buy 10 Nov 2020
Value US$100,720.00 | Price 2.01 | Shares 50,000
Planned sale 3 Jan 2020
Value US$8,002.80 | Price 3.42 | Shares 2,340
Sale 3 Jan 2020
Value US$8,002.80 | Price 3.42 | Shares 2,340
Sale 2 Jan 2020
Value US$3,219.24 | Price 3.86 | Shares 834
Sale 2 Oct 2019
Value US$6,194.60 | Price 1.88 | Shares 3,295
Sale 1 Oct 2019
Value US$14,422.32 | Price 1.98 | Shares 7,284
Sale 27 Sep 2019
Value US$1,861.86 | Price 1.86 | Shares 1,001
Buy 24 Sep 2019
Value US$57,240.00 | Price 1.91 | Shares 30,000
Buy 24 Sep 2019
Value US$100,101.75 | Price 1.91 | Shares 52,500
Sale 8 Mar 2019
Value US$5,612.00 | Price 2.44 | Shares 2,300
Sale 7 Mar 2019
Value US$5,713.57 | Price 2.55 | Shares 2,240
Planned buy 23 May 2018
Value US$1,000,000.20 | Price 4.70 | Shares 212,766
Buy 15 Nov 2017
Value US$453,966.00 | Price 7.57 | Shares 60,000
Buy 12 Sep 2017
Value US$49,838.60 | Price 135.80 | Shares 367
Buy 12 Sep 2017
Value US$49,906.50 | Price 6.79 | Shares 7,350
Buy 7 Jun 2017
Value US$114,129.60 | Price 5.90 | Shares 19,344
Planned buy 6 Jun 2017
Value US$3,870.40 | Price 5.90 | Shares 656
Buy 5 Jun 2017
Value US$89,211.00 | Price 118.95 | Shares 750
Planned buy 5 Jun 2017
Value US$89,211.00 | Price 5.95 | Shares 15,000
Buy 31 Mar 2017
Value US$99,975.00 | Price 155.00 | Shares 645
Planned buy 31 Mar 2017
Value US$99,975.00 | Price 7.75 | Shares 12,900
Planned buy 31 Mar 2017
Value US$96,875.00 | Price 7.75 | Shares 12,500
Planned buy 20 May 2016
Value US$50,224.68 | Price 11.53 | Shares 4,356
Buy 20 May 2016
Value US$49,608.10 | Price 11.51 | Shares 4,310
Buy 25 Nov 2015
Value US$20,280.00 | Price 15.60 | Shares 1,300
Buy 24 Nov 2015
Value US$80,838.00 | Price 14.97 | Shares 5,400
Buy 23 Nov 2015
Value US$100,848.01 | Price 14.23 | Shares 7,087
Buy 20 Apr 2015
Value US$709,680.00 | Price 16.00 | Shares 44,355
Buy 20 Apr 2015
Value US$2,490,320.00 | Price 16.00 | Shares 155,645
Buy 20 Apr 2015
Value US$3,200,000.00 | Price 16.00 | Shares 200,000
Buy 20 Apr 2015
Value US$80,000.00 | Price 16.00 | Shares 5,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-12 2025-12-10 PlS Planned sale
Ward Shane

COO & CLO

Officer
20,524 +46.9%
387.76
US$4,412,843 		20,524 +46.9% 387.76 US$4,412,843
2025-09-15 2025-09-11 PlS Planned sale
Davarpanah Nicole Negar

Chief Medical Officer

Officer
12,876 -30.3%
380.26
US$3,577,066 		12,876 -30.3% 380.26 US$3,577,066
2025-06-30 2025-06-26 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
84,621 +14.1%
264.45
US$4,681,910 		84,621 +14.1% 264.45 US$4,681,910
2025-06-04 2025-06-03 B Purchase
3.7
Mineo Chrysa
Non-Executive Director
1,050 +46.3%
23.44
US$24,614 		1,050 +46.3% 23.44 US$24,614
2025-06-04 2025-06-02 B Purchase
3.7
Mineo Chrysa
Non-Executive Director
2,270 +inf%
21.71
US$49,281 		2,270 +inf% 21.71 US$49,281
2025-03-13 2025-03-11 PlS Planned sale
3.6
Tari Leslie

CHIEF SCIENTIFIC OFFICER

Officer
1,773 -9.9%
21.96
US$38,940 		1,773 -9.9% 21.96 US$38,940
2025-03-13 2025-03-11 PlS Planned sale
Ward Shane

COO & CLO

Officer
1,664 -10.2%
21.96
US$36,542 		1,664 -10.2% 21.96 US$36,542
2024-09-13 2024-09-11 PlS Planned sale
Sandison Taylor

Chief Medical Officer

Officer
924 -3.9%
11.64
US$10,752 		924 -3.9% 11.64 US$10,752
2024-09-13 2024-09-11 PlS Planned sale
3.6
Tari Leslie

CHIEF SCIENTIFIC OFFICER

Officer
909 -4.9%
11.64
US$10,580 		909 -4.9% 11.64 US$10,580
2024-06-11 2024-06-07 B Purchase
2.5
Stein Jeffrey

President & CEO

Executive Director
8,000 +48.3%
13.21
US$105,680 		8,000 +48.3% 13.21 US$105,680
2024-03-12 2024-03-11 PlS Planned sale
3.6
Tari Leslie

CHIEF SCIENTIFIC OFFICER

Officer
21,029 -7.5%
0.67
US$14,085 		21,029 -7.5% 0.67 US$14,085
2024-03-12 2024-03-11 PlS Planned sale
1.4
Shah Preetam

CFO & CBO

Officer
18,931 -7.7%
0.67
US$12,680 		18,931 -7.7% 0.67 US$12,680
2024-03-12 2024-03-11 PlS Planned sale
Ward Shane

COO & CLO

Officer
20,473 -9.3%
0.67
US$13,713 		20,473 -9.3% 0.67 US$13,713
2024-03-12 2024-03-11 PlS Planned sale
Sandison Taylor

Chief Medical Officer

Officer
20,662 -5.6%
0.67
US$13,839 		20,662 -5.6% 0.67 US$13,839
2023-09-13 2023-09-11 PlS Planned sale
Sandison Taylor

Chief Medical Officer

Officer
18,793 -4.9%
0.95
US$17,810 		18,793 -4.9% 0.95 US$17,810
2023-09-13 2023-09-11 S Sale
3.6
Tari Leslie

CHIEF SCIENTIFIC OFFICER

Officer
18,469 -6.3%
0.95
US$17,509 		18,469 -6.3% 0.95 US$17,509
2023-08-14 2023-08-14 PP Planned purchase
3.6
Tari Leslie

CHIEF SCIENTIFIC OFFICER

Officer
10,000 +3.5%
0.97
US$9,700 		10,000 +3.5% 0.97 US$9,700
2023-08-08 2023-08-08 B Purchase
2.5
Stein Jeffrey

President & CEO

Executive Director
50,000 +17.8%
0.96
US$47,885 		50,000 +17.8% 0.96 US$47,885
2023-03-27 2023-03-27 B Purchase
2.5
Stein Jeffrey

President & CEO

Executive Director
50,000 +21.6%
1.04
US$51,855 		50,000 +21.6% 1.04 US$51,855
2023-03-13 2023-03-13 PlS Planned sale
Sandison Taylor

Chief Medical Officer

Officer
7,203 -2.4%
1.53
US$11,021 		7,203 -2.4% 1.53 US$11,021
2023-03-13 2023-03-13 PlS Planned sale
Ward Shane

COO & CLO

Officer
4,329 -4.9%
1.53
US$6,623 		4,329 -4.9% 1.53 US$6,623
2023-03-13 2023-03-13 S Sale
3.6
Tari Leslie

CHIEF SCIENTIFIC OFFICER

Officer
7,562 -3.8%
1.53
US$11,570 		7,562 -3.8% 1.53 US$11,570
2023-03-13 2023-03-13 PlS Planned sale
1.4
Shah Preetam

CFO & CBO

Officer
6,648 -4.3%
1.53
US$10,171 		6,648 -4.3% 1.53 US$10,171
2023-01-27 2023-01-12 S Sale
3.6
Tari Leslie

CHIEF SCIENTIFIC OFFICER

Officer
11,814 -88.8%
1.20
US$14,177 		11,814 -88.8% 1.20 US$14,177
2022-09-19 2022-09-19 S Sale
1.4
Shah Preetam

CFO & CBO

Officer
15,642 -9.4%
0.77
US$12,035 		15,642 -9.4% 0.77 US$12,035
2022-09-13 2022-09-12 S Sale
3.2
Daruwala Paul

Chief Operating Officer

Officer
16,199 -6.8%
0.68
US$11,095 		16,199 -6.8% 0.68 US$11,095
2022-09-13 2022-09-12 PlS Planned sale
Sandison Taylor

Chief Medical Officer

Officer
18,478 -6.0%
0.68
US$12,656 		18,478 -6.0% 0.68 US$12,656
2022-09-13 2022-09-12 PlS Planned sale
3.6
Tari Leslie

CHIEF SCIENTIFIC OFFICER

Officer
18,159 -8.6%
0.68
US$12,437 		18,159 -8.6% 0.68 US$12,437
2022-03-23 2022-03-21 S Sale
3.4
Johnson Brady

Vice President, Finance

Officer
654 -1.3%
0.81
US$530 		654 -1.3% 0.81 US$530
2022-03-11 2022-03-11 S Sale
3.4
Johnson Brady

Vice President, Finance

Officer
945 -1.9%
0.71
US$671 		945 -1.9% 0.71 US$671
2022-01-07 2022-01-05 S Sale
3.6
Tari Leslie

Chief Scientific Officer

Officer
1,252 -0.8%
1.25
US$1,565 		1,252 -0.8% 1.25 US$1,565
2022-01-07 2022-01-05 S Sale
3.2
Daruwala Paul

Chief Operating Officer

Officer
5,133 -2.7%
1.25
US$6,416 		5,133 -2.7% 1.25 US$6,416
2022-01-07 2022-01-05 S Sale
3.4
Johnson Brady

Vice President, Finance

Officer
416 -0.8%
1.25
US$520 		416 -0.8% 1.25 US$520
2021-11-15 2021-11-12 B Purchase
2.5
Stein Jeffrey

President & CEO

Executive Director
50,000 +12.0%
1.59
US$79,530 		50,000 +12.0% 1.59 US$79,530
2021-11-15 2021-11-12 B Purchase
1.4
Shah Preetam

CFO & CBO

Officer
20,000 +inf%
1.54
US$30,800 		20,000 +inf% 1.54 US$30,800
2021-09-14 2021-09-13 B Purchase
0.6
Franson Timothy R
Non-Executive Director
7,000 +175.0%
2.12
US$14,822 		7,000 +175.0% 2.12 US$14,822
2021-04-05 2021-04-01 S Sale
3.2
Oien Jessica

General Counsel & Secretary

Officer
1,177 -13.2%
2.66
US$3,131 		1,177 -13.2% 2.66 US$3,131
2021-04-05 2021-04-01 S Sale
3.2
Daruwala Paul

Chief Operating Officer

Officer
593 -1.2%
2.66
US$1,577 		593 -1.2% 2.66 US$1,577
2021-04-05 2021-04-01 S Sale
2.0
Abdollahian Neil

Chief Business Officer

Officer
1,469 -2.5%
2.66
US$3,908 		1,469 -2.5% 2.66 US$3,908
2021-04-05 2021-01-05 S Sale
3.2
Oien Jessica

General Counsel & Secretary

Officer
824 -11.8%
2.06
US$1,697 		824 -11.8% 2.06 US$1,697
2021-04-05 2021-01-05 S Sale
3.2
Daruwala Paul

Chief Operating Officer

Officer
2,868 -5.5%
2.06
US$5,908 		2,868 -5.5% 2.06 US$5,908
2021-04-05 2021-01-05 S Sale
2.0
Abdollahian Neil

Chief Business Officer

Officer
2,868 -4.9%
2.06
US$5,908 		2,868 -4.9% 2.06 US$5,908
2026-01-07 2020-11-10 B Purchase
2.5
Stein Jeffrey

President & CEO

Executive Director
2,500 +3.7%
40.01
US$100,015 		2,500 +3.7% 40.01 US$100,015
2020-11-12 2020-11-10 PP Planned purchase
2.5
Stein Jeffrey

President & CEO

Executive Director
50,000 +16.8%
2.00
US$100,015 		50,000 +16.8% 2.00 US$100,015
2020-11-12 2020-11-10 B Purchase
3.3
Levine James E.

Chief Financial Officer

Officer
50,000 +inf%
2.01
US$100,720 		50,000 +inf% 2.01 US$100,720
2020-01-06 2020-01-03 PlS Planned sale
2.0
Abdollahian Neil

Chief Business Officer
2,340 -4.4%
3.42
US$8,003 		2,340 -4.4% 3.42 US$8,003
2020-01-06 2020-01-03 S Sale
3.2
Daruwala Paul

Chief Operating Officer
2,340 -4.2%
3.42
US$8,003 		2,340 -4.2% 3.42 US$8,003
2020-01-06 2020-01-02 S Sale
3.2
Oien Jessica

General Counsel & Secretary
834 -10.7%
3.86
US$3,219 		834 -10.7% 3.86 US$3,219
2019-10-03 2019-10-02 S Sale
3.2
Daruwala Paul

Chief Operating Officer
3,295 -5.6%
1.88
US$6,195 		3,295 -5.6% 1.88 US$6,195
2019-10-03 2019-10-01 S Sale
2.0
Abdollahian Neil

Chief Business Officer
7,284 -12.8%
1.98
US$14,422 		7,284 -12.8% 1.98 US$14,422
2019-10-01 2019-09-27 S Sale
3.2
Oien Jessica

General Counsel & Secretary
1,001 -11.4%
1.86
US$1,862 		1,001 -11.4% 1.86 US$1,862
2019-09-26 2019-09-24 B Purchase
3.3
Levine James E.

Chief Financial Officer
30,000 +17.1%
1.91
US$57,240 		30,000 +17.1% 1.91 US$57,240
2019-09-26 2019-09-24 B Purchase
2.5
Stein Jeffrey

President & CEO

Executive Director
52,500 +30.3%
1.91
US$100,102 		52,500 +30.3% 1.91 US$100,102
2019-03-08 2019-03-08 S Sale
2.0
Abdollahian Neil

Chief Business Officer
2,300 -7.0%
2.44
US$5,612 		2,300 -7.0% 2.44 US$5,612
2019-03-08 2019-03-07 S Sale
3.2
Daruwala Paul

Chief Operating Officer
2,240 -4.3%
2.55
US$5,714 		2,240 -4.3% 2.55 US$5,714
2018-05-24 2018-05-23 PP Planned purchase Stein Jeffrey

President & CEO

Executive Director
212,766 +383.0%
4.70
US$1,000,000 		212,766 +383.0% 4.70 US$1,000,000
2017-11-16 2017-11-15 B Purchase BIOTECH TARGET N V Large shareholder
60,000 +2.7%
7.57
US$453,966 		60,000 +2.7% 7.57 US$453,966
2026-01-07 2017-09-12 B Purchase
2.5
Stein Jeffrey

President & CEO

Executive Director
367 +0.6%
135.80
US$49,839 		367 +0.6% 135.80 US$49,839
2017-09-12 2017-09-12 B Purchase Stein Jeffrey

President & CEO

Executive Director
7,350 +16.5%
6.79
US$49,906 		7,350 +16.5% 6.79 US$49,906
2017-06-08 2017-06-07 B Purchase Sandison Taylor

Chief Medical Officer
19,344 +304.6%
5.90
US$114,130 		19,344 +304.6% 5.90 US$114,130
2017-06-08 2017-06-06 PP Planned purchase Sandison Taylor

Chief Medical Officer
656 +11.5%
5.90
US$3,870 		656 +11.5% 5.90 US$3,870
2026-01-07 2017-06-05 B Purchase
2.5
Stein Jeffrey

President & CEO

Executive Director
750 +1.1%
118.95
US$89,211 		750 +1.1% 118.95 US$89,211
2017-06-07 2017-06-05 PP Planned purchase Stein Jeffrey

President & CEO

Executive Director
15,000 +50.8%
5.95
US$89,211 		15,000 +50.8% 5.95 US$89,211
2026-01-07 2017-03-31 B Purchase
2.5
Stein Jeffrey

President & CEO

Executive Director
645 +1.0%
155.00
US$99,975 		645 +1.0% 155.00 US$99,975
2017-04-04 2017-03-31 PP Planned purchase Stein Jeffrey

President & CEO

Executive Director
12,900 +90.2%
7.75
US$99,975 		12,900 +90.2% 7.75 US$99,975
2017-04-04 2017-03-31 PP Planned purchase Forrest Kevin

Chief Scientific Officer
12,500 +20.9%
7.75
US$96,875 		12,500 +20.9% 7.75 US$96,875
2016-05-23 2016-05-20 PP Planned purchase
Forrest Kevin

COO & CFO

Officer
4,356 +8.1%
11.53
US$50,225 		4,356 +8.1% 11.53 US$50,225
2016-05-23 2016-05-20 B Purchase Stein Jeffrey

President & CEO

Executive Director
4,310 +2.2%
11.51
US$49,608 		4,310 +2.2% 11.51 US$49,608
2015-11-27 2015-11-25 B Purchase Stein Jeffrey

President & CEO

Executive Director
1,300 +24.1%
15.60
US$20,280 		1,300 +24.1% 15.60 US$20,280
2015-11-27 2015-11-24 B Purchase Stein Jeffrey

President & CEO

Executive Director
5,400 +inf%
14.97
US$80,838 		5,400 +inf% 14.97 US$80,838
2015-11-23 2015-11-23 B Purchase Forrest Kevin

COO & CFO

Officer
7,087 +15.9%
14.23
US$100,848 		7,087 +15.9% 14.23 US$100,848
2015-04-22 2015-04-20 B Purchase Heron Patrick J Non-Executive Director
44,355 +inf%
16.00
US$709,680 		44,355 +inf% 16.00 US$709,680
2015-04-22 2015-04-20 B Purchase Kjellson Nina S Non-Executive Director
200,000 +inf%
16.00
US$3,200,000 		200,000 +inf% 16.00 US$3,200,000
2015-04-22 2015-04-20 B Purchase Heron Patrick J Non-Executive Director
155,645 +inf%
16.00
US$2,490,320 		155,645 +inf% 16.00 US$2,490,320
2015-04-21 2015-04-20 B Purchase PEREZ ROBERT J Non-Executive Director
5,000 +inf%
16.00
US$80,000 		5,000 +inf% 16.00 US$80,000
Explore more

More insider trading research around Cidara Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America